Product Images Famotidine

This appears to be a medication dosage tracking table for Famotidine, with dosages of 20mg twice daily (biid) being given to 84 individuals. The table indicates that after 2 weeks, there was a 3% response rate, and after 4 weeks, there was a 67% response rate. It is possible that Famotidine is being used to treat a medical condition, but further context is necessary to confirm this.*

This appears to be a table showing the results of a study involving two medications (Famolidine and Famotidine) and a placebo treatment. The dosages used were 40mg taken at bedtime. The study included a total of 149 participants and lasted 8 weeks. The numbers represent the percentage of participants who experienced certain outcomes (which are not specified). It is difficult to determine what these outcomes were without more information or context.*

The text describes a clinical trial evaluating the effectiveness of Famotidine in two different doses (20 mg and 40 mg) compared to a placebo. The trial involved a total of 276 participants (154 in the Famotidine group and 149 in the placebo group) with data collected at week 6. The text does not provide further details about the purpose of the trial or the outcomes measured.*

This appears to be a table presenting the results of a study comparing the effects of Famotidine (presumably a medication) at 40mg/day and 20mg/day doses with a Placebo on a group of 127 participants. The N values (number of participants) for each group are given as well as the time in weeks of treatment (up to 12 weeks). However, it is not clear what the exact measures being studied are as the text is incomplete and contains several errors.*

This appears to be a table displaying the dosage and effectiveness of three different medications (Famotidine, Famotidine, and Ranitidine) over the course of 52 weeks, based on a sample size of 93 or 172 individuals. The dosages listed are 4mg, 20mg, and 150mg taken once or twice a day. The numbers in the table indicate the percentage of participants who experienced effectiveness or relief from symptoms of their condition at weeks 6, 8, 12, and 52.*

This appears to be a chart showing the dosage, route, and effect of a medication on different groups of patients. The medication seems to affect gastric pH levels, with various dosages and durations of effect listed for different age ranges. However, some of the information is unclear, particularly in the second to last line which has an incomplete sentence.*

These are Famotidine Tablets, USP containing 20mg each and come in a pack of 10 tablets. The storage temperature for these tablets is between 20 to 25 degrees Celsius. This product is for institutional use only and is Rx only. The package is not child-resistant, so one should keep it out of the children's reach. The manufacturer is Carlsbad Technology, Inc. and the distributor is McKesson Corporation dba SKY Packaging. This medication is for oral use only. However, the usual dosage is not available so please refer to the product insert or full prescribing information for precautions and warnings.*